Correction to: Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals

BMC Med. 2022 Mar 23;20(1):121. doi: 10.1186/s12916-022-02308-1.

Ruiqi Zhang^{1

2}, Jil Billy Mamza², Tamsin Morris², George Godfrey², Folkert W Asselbergs^{3

4

5}, Spiros Denaxas^{3

6}, Harry Hemingway^{3

6}, Amitava Banerjee^{7

8

9

10}

¹ Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
² Medical and Scientific Affairs, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
³ Institute of Health Informatics, University College London, London, UK.
⁴ Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
⁵ Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.
⁶ Health Data Research UK London, University College London, London, UK.
⁷ Institute of Health Informatics, University College London, London, UK. ami.banerjee@ucl.ac.uk.
⁸ Health Data Research UK London, University College London, London, UK. ami.banerjee@ucl.ac.uk.
⁹ Barts Health NHS Trust, London, UK. ami.banerjee@ucl.ac.uk.
¹⁰ University College London Hospitals NHS Trust, London, UK. ami.banerjee@ucl.ac.uk.

No abstract available

Publication types